FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Wound Healing topics
Wound Healing
Amino Acid
Amino Acid Sequence
Proliferation
Theophylline
Inflammation
Antimicrobial
Epithelial
Amino Acids
Skin Graft
Bone Healing
Vascular Disease
Skin Ulcer
Bacterial Infection
Dysfunction

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Wound Healing patents



      
           
This page is updated frequently with new Wound Healing-related patent applications. Subscribe to the Wound Healing RSS feed to automatically get the update: related Wound RSS feeds. RSS updates for this page: Wound Healing RSS RSS


Radially tensioned wound or skin treatment devices and methods

Date/App# patent app List of recent Wound Healing-related patents
08/21/14
20140235727
 Antimicrobial hydrogel polymers patent thumbnailAntimicrobial hydrogel polymers
The present invention relates generally to antimicrobial hydrogel polymers, and dressings comprising one or more hydrogel-forming hydrophilic polymers, where the hydrogels and dressings further comprise one or more antimicrobial agents that are released from the hydrogel in a controlled manner. The hydrogels and dressings may be used for medical, veterinary, and/or cosmetic applications.
08/21/14
20140234419
 Methods and compositions for wound healing patent thumbnailMethods and compositions for wound healing
The present invention relates to methods and compositions for wound healing. In particular, the present invention relates to promoting and enhancing wound healing by utilizing cross-linker covalent modification molecules to attach and deliver wound active agents to a wound.
08/14/14
20140228731
 Radially tensioned wound or skin treatment devices and methods patent thumbnailRadially tensioned wound or skin treatment devices and methods
Devices, kits and methods described herein may be for treatment to skin, including but not limited to wound healing, the treatment, amelioration, and/or prevention of scars or keloids. An applicator and/or tensioning device may be used to apply a dressing to a subject.
08/14/14
20140228430
 Method of accelerating corneal wound healing patent thumbnailMethod of accelerating corneal wound healing
The topical ophthalmic use of 5,6,7-trihydroxyheptanoic acid and analogs for the acceleration of corneal wound healing in humans, is disclosed.. .
08/14/14
20140227341
 Methods of using regenerative cells to promote wound healing patent thumbnailMethods of using regenerative cells to promote wound healing
Cells present in adipose tissue are used to promote wound healing in a patient. Methods of treating patients include processing adipose tissue to deliver a concentrated amount of regenerative cells obtained from the adipose tissue to a patient.
08/14/14
20140227339
 Regenerative tissue grafts and methods of making same patent thumbnailRegenerative tissue grafts and methods of making same
A graft containing a scaffold that includes a matrix in which are positioned mesenchymal progenitor cells (mpcs) has the capacity to substantially improve wound healing, including wounds resulting from injury to nerve, bone and vascular tissue. Mpcs can be harvested from debrided muscle tissue following orthopaedic trauma.
08/14/14
20140227234
 Methods of using regenerative cells to promote wound healing patent thumbnailMethods of using regenerative cells to promote wound healing
Cells present in adipose tissue are used to promote wound healing in a patient. Methods of treating patients include processing adipose tissue to deliver a concentrated amount of regenerative cells obtained from the adipose tissue to a patient.
08/14/14
20140227231
 Laminins, derivatives, and compositions including same and methods for their therapeutic use patent thumbnailLaminins, derivatives, and compositions including same and methods for their therapeutic use
In various embodiments, the present disclosure provides a method of treating a subject using laminin or a composition that includes laminin. In one embodiment, the method is used to enhance muscle regeneration, maintenance, or repair in a subject.
08/07/14
20140221903
 Combination of an oxidant and a photoactivator for the healing of wounds patent thumbnailCombination of an oxidant and a photoactivator for the healing of wounds
There is provided a wound healing composition which comprises at least one oxidant, at least one photoactivator capable of activating the oxidant and at least one healing factor chosen from hyaluronic acid, glucosamine and allantoin in association with a pharmaceutically acceptable carrier. In addition, a method of topically treating wounds using at least one oxidant and at least one photoactivator capable of activating the oxidant followed by illumination of said photosensitizer is disclosed..
08/07/14
20140221407
 Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm- related clinical pathologies patent thumbnailUse and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm- related clinical pathologies
Pharmaceutical compositions comprising tricyclic 3,4-propinoperhydropurines and uses thereof for the treatment of facial wrinkling are provided.. .
08/07/14
20140220161
Compositions and methods to modulate angiogenesis
The present invention provides methods of stimulating angiogenesis and the growth or migration of cells associated with angiogenesis, by contacting animals, tissues, or cells with sulfide, alone or in combination with nitric oxide. These methods may be used for a variety of purposes, including promoting wound healing, increasing blood flow, and for the treatment and prevention of diseases and disorders associated with decreased blood flow, including ischemic or hypoxic injury..
08/07/14
20140220130
Device for promotion of hemostasis and/or wound healing
The present invention relates to a matrix material comprising a pharmaceutical composition such as a matrix material with a pharmaceutical composition printed on the surface. In one embodiment the pharmaceutical composition comprises thrombin.
08/07/14
20140220094
Methods and compositions for a laparoscopic surgery
Glycerophosphate salts have been found to drastically improve a laparoscopic surgery by reducing the inflammatory response inflicted by the surgery and enhancing wound healing. Methods and devices for improving the laparoscopic surgery using a composition comprising an effective amount of a glycerophosphate salt are described..
08/07/14
20140220085
Method for tissue engineering
In an embodiment of the disclosure, a biomedical material is provided. The biomedical material includes a biocompatible material having a surface and a carrier distributed over the surface of the biocompatible material, wherein both of the biocompatible material and the carrier have no charges, one of them has charges or both of them have charges with different electricity.
08/07/14
20140220052
Compositions and methods for wound healing, and for recruitment and activation of macrophages in injured tissues and in implanted biomaterials used for tissue engineering
The present invention is related to the field of wound healing or tissue regeneration due to disease (i.e., for example, cardiovascular diseases, osetoarthritic diseases, or diabetes) and to healing of internal injuries. In particular, the present invention provides compositions and methods comprising molecules and nanoparticles with linked α-gal epitopes for induction of recruitment and activation of macrophages localized within or surrounding damaged and/or injured tissue.
08/07/14
20140220040
Antibodies to lrp6
Anti-lrp6 antibodies and antigen-binding fragments thereof, as well as pharmaceutical compositions comprising such antibodies and antigen-binding fragments are described. These anti-lrp6 antibodies can be used to enhance wnt activity and/or antagonize dkk1 activity.
08/07/14
20140219991
Treatment and composition for wound healing
Delivery systems including gels, sponges, gauzes and meshes incorporating the agent for topical administration are also described.. .
08/07/14
20140219933
Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfection and treatment of oral disease
The present document describes methods of use of photo activated compositions for oral disinfection and/or treatments which comprise at least one oxidant, at least one photoactivator capable of activating the oxidant, and at least one healing factor chosen from hyaluronic acid, glucosamine and allantoin, in association with a pharmacologically acceptable carrier.. .
07/24/14
20140207050
Use of local anesthesia and electrical stimulation in peripheral wound treatment
A wound therapy method that results in improved wound healing for conditions including diabetic foot ulcers, pressure ulcers, and arterial and venous ulcers is described. The wound therapy method uses local anesthetic injections in an area surrounding the wound combined with electrical stimulation causing local and deep muscle contraction in the same area.
07/17/14
20140200219
Methods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie's disease, arteriosclerosis and other fibrotic diseases
The present methods and compositions are of use for treatment of conditions involving fibrosis, such as peyronie's disease plaque, penile corporal fibrosis, penile veno-occlusive dysfunction, dupuytren's disease nodules, vaginal fibrosis, clitoral fibrosis, female sexual arousal disorder, abnormal wound healing, keloid formation, general fibrosis of the kidney, bladder, prostate, skin, liver, lung, heart, intestines or any other localized or generalized fibrotic condition, vascular fibrosis, arterial intima hyperplasia, atherosclerosis, arteriosclerosis, restenosis, cardiac hypertrophy, hypertension or any condition characterized by excessive fibroblast or smooth muscle cell proliferation or deposition of collagen and extracellular matrix in the blood vessels and/or heart. In certain embodiments, the compositions may comprise a pde-4 inhibitor, a pde-5 inhibitor, a compound that elevates cgmp and/or pkg, a stimulator of guanylyl cyclase and/or pkg, a combination of a compound that elevates cgmp, pkg or no with an antioxidant that decreases ros, or a compound that increases mmp activity..
07/17/14
20140200196
Hydrogel tattoo protection and aftercare system
A wound care dressing that combines a sodium alginate hydrogel spread and a calcium solution spray to create a transparent membrane over damaged skin eliminating the need for a secondary dressing. The calcium dissolved in alcohol displaces sodium from the hydrogel spread, resulting in the formation of the membrane.
07/17/14
20140199367
Topical transdermal method for delivering nutrients through the skin for expeditied wound healing and skin rejuvenation
This delivery system bypasses digestion and dilution. Key is a lipophilic carrier with nuclear and mitochondrial ligands that rapidly penetrate and permeate all membranes and truncates the inflammatory site quickly manifesting curation.
07/10/14
20140194451
Cdc42 inhibitor and uses thereof
Compounds which inhibit the small g protein rho gtpase cell division cycle protein cdc42 are provided. Morphological analyses of filopodia, western blots of ccd42 phosphorylation, and effects on cellular wound healing and on growth cone formation all demonstrate that the described compounds are able to inhibit all tested cdc42-mediated processes.
07/10/14
20140193431
Anti-c-met antibody having hgf activity and use thereof
Disclosed are a human antibody comprising a human complementarity-determining region (cdr), which binds specifically to c-met, and a framework region (fr), a polynucleotide encoding the human antibody, an expression vector comprising the polynucleotide, a transformant transformed with the expression vector, a method of producing the human antibody b7 by culturing the transformant, a wound healing composition comprising the human antibody as an active ingredient, a cell regeneration composition comprising the antibody as an active ingredient, and a drug conjugate comprising a drug linked to the human antibody. The c-met-specific human antibody can function as an hgf mimic that can be used as a wound healing composition.
07/10/14
20140193368
Pluripotent therapeutic compositions and uses thereof
Synthetic stem cell-like tissue healing and regeneration medication with anti-inflammatory, protein synthesis, enzyme deficiency activation and genetic therapy, and anti-cancer agent derived from a series of inventions that include these products of biomolecular engineering, drug discovery from a biologic periodic table of applied biochemistry and biophysics. Tissue has a self healing effect promoting tissue healing and tissue regeneration.
07/03/14
20140186455
Tissue repair system
An implant for promoting accelerated wound healing. The implant comprises a non-flocculating fiber material, admixed with a settable fluid.
06/26/14
20140178344
Acrylamide hydrogels for tissue engineering
Disclosed are acrylamide hydrogels prepared from derivatives of (tetrahydropyranyl)methyl- and (tetrahydrofuranyl)methyl-acrylamide, methods of making the same, and methods of wound healing or tissue generation with acrylamide hydrogels.. .
06/19/14
20140171358
Antimicrobial compositions comprising dgla and neomycin sulfate and methods of use thereof
The present disclosure provides compositions comprising fatty acids, or derivatives thereof (e.g., c1-c4 esters) including, for example, dgla, 15-ohepa and/or 15-hetre, used alone or in combination with one or more antibiotic agents for the treatment of disease and/or disorders such as a skin infection or wound healing.. .
06/12/14
20140163051
Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm- related clinical pathologies
Pharmaceutical compositions comprising tricyclic 3,4-propinoperhydropurines and uses thereof for the treatment of facial wrinkling are provided.. .
06/12/14
20140161776
Mesenchymal stem cells and uses therefor
Compositions and methods of promoting wound healing in a human by administering to the human mesenchymal stem cells in an effective amount.. .
06/05/14
20140155322
Method of preventing or reducing scarring of human skin
Insulin or a peroxisome proliferator-activated receptor (ppar) agonist provides reliable and effective prevention of scarring in human skin, or at least a reduction in the severity of scarring. The application of insulin or the ppar agonist to wounds topically or by local injection is particularly advantageous since it simultaneously reduces/prevents scarring whilst enhancing re-epithelialisation of the wound and thus provides a dual action wound healing treatment.
06/05/14
20140154205
Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications
A method of promoting wound healing or connective tissue reconstruction and a method of treating ischemia in a subject in need thereof are disclosed. The methods comprising topically administering to the subject about 10-30 mg per cm2 wound tissue of erythropoietin and about 100-300 mg per cm2 wound tissue of fibronectin, thereby promoting wound healing or connective tissue reconstruction or treating ischemia in the subject.
05/29/14
20140148769
Re-epithelialization wound dressings and systems
Methods, apparatuses, and systems for promoting re-epithelialization as an aspect of wound healing are presented. A re-epithelialization dressing for use with reduced pressure has a moist tissue-interface layer, a manifold member, and a sealing member.
05/29/14
20140148506
Drug elating silicone gel sheeting for wound healing and scar reduction
Provided are compositions of various silicone compounds loaded with active pharmaceutical agents, which are suitable for promoting the healing of skin wounds and the reduction or prevention of scarring.. .
05/29/14
20140148389
Methods for accelerating wound healing by administration of adipokines
The present disclosure provides a method, composition and kit for treatment of inflammatory disease and disorder using pkc isoform modulators.. .
05/29/14
20140147422
Method of deriving stem cells, stem cells, and use of stem cells for wound healing
A method of deriving isolated stem cells including: implanting a matrix in a wound site of a living organism; allowing cells to infiltrate the matrix; removing the matrix containing the infiltrated cells from the wound site; and removing the infiltrated cells from the matrix to provide isolated stem cells. Stem cells produced by this process, stem cells with certain characteristics, and methods for treating wounds using these stem cells are provided..
05/22/14
20140142092
Compounds and methods for skin repair
The disclosure provides compositions and methods for wound healing and scar reduction. The compositions and methods of the invention include at least one mixed ep2/ep4 agonist set forth herein.
05/22/14
20140142042
Skin wound healing and scar reduction with prostaglandin ep4 agonist combinations
A combination of a prostaglandin ep4 agonist and an effective amount of: a prostaglandin ep2 agonist, a skin growth factor, a small peptide, a small inhibitory rna targeting excess chronic inflammation or fibrosis, a cytokine with beneficial anti-inflammatory activity, an adenosine a2a receptor agonist, an anti-oxidant, or a combination thereof, may be used to treat skin wounds or scars.. .
05/22/14
20140141101
Compositions of enhancing wound healing containing magnesium and bromide
The present invention relates to ionic compositions for enhancing wound healing, particularly in the sinonasal cavity. The ionic components of the composition can include potassium, calcium, rubidium, zinc, bromide, and magnesium in an isotonic solution.
05/22/14
20140141050
Bioresorbable wound dressing
The present invention is directed to novel non-woven fabrics containing growth and differentiation factor proteins. Said fabrics are specifically designed to accelerate tissue regeneration and wound healing processes of mammalian tissues.
05/15/14
20140135678
Skin treatment devices with locking mechanisms
Devices, kits and methods described herein may be for wound healing, including the treatment, amelioration, or prevention of scars and/or keloids by applying and/or maintaining a predetermined strain in an elastic skin treatment device that is then affixed to the skin surface using skin adhesives to transfer a generally planar force from the bandage to the skin surface. Applicators are used to apply and/or maintain the strains, and some of the applicators are further configured to provide at least some mechanical advantage to the user when exerting loads onto the skin treatment device..
05/15/14
20140135677
Segmented skin treatment systems and methods
Devices, kits and methods described herein may be for wound healing, including the treatment, amelioration, or prevention of scars and/or keloids by applying and/or maintaining a pre-determined strain in an elastic skin treatment device that is then affixed to the skin surface using skin adhesives to transfer a generally planar force from the bandage to the skin surface. Applicators are used to apply and/or maintain the strains, and some of the applicators are further configured to provide at least some mechanical advantage to the user when exerting loads onto the skin treatment device..
05/15/14
20140134273
Methods of enhancing wound healing using magnesium and bromide
The present invention relates to ionic compositions for enhancing wound healing, particularly in the sinonasal cavity. The ionic components of the composition can include potassium, calcium, rubidium, zinc, bromide, and magnesium in an isotonic solution.
05/15/14
20140134272
Methods of enhancing wound healing
The present invention relates to ionic compositions for enhancing wound healing, particularly in the sinonasal cavity. The ionic components of the composition can include potassium, calcium, rubidium, zinc, bromide, and magnesium in an isotonic solution.
05/15/14
20140134238
Tannin-chitosan composites
The invention provides a composition comprising a matrix of chitosan and a tannin wherein the chitosan is electrostatically bonded to the tannin to form a chitosan-tannin composite material. The chitosan can be partially or fully deacetylated, and the tannin can be a monomeric or an oligomeric proanthocyanidin or a hydrolysable tannin.
05/08/14
20140127277
Method of preparing coating film containing nitrogen monoxide on surface of material using catecholamine
A method of coating surfaces of various body-implantable materials with control-releasable nitrogen monoxide using a catecholamine, more particularly, technology of preparing a coating film containing a diazeniumdiolate functional group on a surface of a material to be coated using a catecholamine, is provided. The coating film prepared by the method has advantages in that nitrogen monoxide can be stably supplied under an in vivo environment, and can be suitably used in a living body without causing cytotoxicity.
05/01/14
20140121631
Variable intensity laser treatments of the skin
A method for providing localized heating of the dermal layers of skin of a patient, using energy in the form of a group of pulses having defined parameters in a controlled manner. This method preferably uses an optical delivery system to deliver pulsed energy to a specific spot of skin so that targeted layers of the affected skin are heated to a desired temperature range.
05/01/14
20140120057
Polymers and methods thereof for wound healing
Wherein y is 1 or more. Other embodiments of the invention provide a therapeutic method for treating a wound in an animal comprising administering to an animal in need of such therapy, an effective amount of a copolymer as described herein..
04/24/14
20140112898
Unique population of regulatory t cells that regulate tissue regeneration and wound healing
A unique type of regulatory t cell has been identified in muscle. These tissue-regenerative treg cells play a role in regulating wound healing.
04/17/14
20140107682
Dissection handpiece and method for reducing the appearance of cellulite
A dermatological skin treatment device is provided. The device comprises a handpiece and a cutting tool, wherein the tool is inserted through the conduit and percutaneously inserted into a tissue disposed within a recessed area of the handpiece.
04/17/14
20140107600
Reduced-pressure wound dressings and systems for re-epithelialization and granulation
Methods for promoting re-epithelialization and granulation as an aspect of wound healing are presented. A method for promoting granulation and re-epithelialization of a wound at the same time involves using a reduced-pressure treatment dressing and applying a moist, water-sensitive barrier to promote re-epithelialization and to inhibit granulation.
04/17/14
20140107025
Ocular drug delivery system
An ocular drug delivery system including a composition in which a formulation having an active agent such as rhgh and or an rhgh mimic, e.g., that increases insulin growth factor (igf) or that alters insulin growth factor binding protein (igfbp) in a subject is dispersed in a pharmaceutical carrier. The composition is configured for placement in, around or on an eye of the subject, and the composition provides controlled release of an amount of the active agent to the eye effective to promote ocular surface and corneal neural regeneration and wound healing..
04/03/14
20140094502
Rnai inhibition of ctgf for treatment of ocular disorders
Rna interference is provided for inhibition of connective tissue growth factor mrna expression in ocular disorders involving ctgf expression. Ocular disorders involving aberrant ctgf expression include glaucoma, macular degeneration, diabetic retinopathy, choroidal neovascularization, proliferative vitreoretinopathy and wound healing.
04/03/14
20140094467
Method and composition for modulating canonical wnt pathway using folate and inositol
The canonical wnt signaling pathway is implicated in many disorders including neural tube defects, limb malformations, and heart defects, developmental disorders associated with alcohol exposure (fetal alcohol syndrome) or exposure to bipolar medications (i.e. Lithium), wound healing, and alzheimer's disease.
04/03/14
20140094413
Hepatocyte growth factor (hgf) mimics as therapeutic agents
Small molecule, peptidic hepatocyte growth factors mimics, which act as both mimetics and antagonists, have been generated. These molecules have been shown or predicted to have therapeutic potential for numerous pathologies including dementia, alzheimer's disease, parkinson's disease, amyotrphic lateral sclerosis, and other neurodegenerative diseases, spinal cord injury, traumatic brain injury, diabetes and metabolic syndrome, cancer, and defective wound healing..
04/03/14
20140093593
Decubitus treatment system
The present invention includes compositions and methods for cleaning, treating, protection and resolution of decubitus ulcers comprising: a first composition comprising a wound cleaning solution comprising aloe vera gel comprising at least 5,000 mps, a balanced salt solution; and a second composition comprising a wound healing gel comprising aloe vera gel comprising at least 10,000 mps, a thickening agent, and one or more preservatives and, optionally, a third composition comprising a moisture barrier cream comprising a vegetable-based emulsifier, a cosmetic ester for dry skin that has low occlusivity, an ester-based emollient that is oxidation stable and has low occlusivity; a beeswax; a hydrogenated oil, glycerin, a buffering agent, aloe vera gel comprising at least 2,000 mps and water.. .
03/27/14
20140088563
Method of deriving stem cells, stem cells, and use of stem cells for wound healing
A method of deriving isolated stem cells including: implanting a matrix in a wound site of a living organism; allowing cells to infiltrate the matrix; removing the matrix containing the infiltrated cells from the wound site; and removing the infiltrated cells from the matrix to provide isolated stem cells. Stem cells produced by this process, stem cells with certain characteristics, and methods for treating wounds using these stem cells are provided..
03/27/14
20140088489
Wound care apparatus
The invention is applicable to the field of medical care products, and provides a wound care apparatus. The wound care apparatus comprises a pump and a sealed dressing connected to the pump via a first pipeline, a laser being disposed at the upper end of the sealed dressing.
03/27/14
20140088481
Controlled strain skin treatment devices and methods
Devices, kits and methods described herein may be for wound healing, including but not limited to the treatment, amelioration, or prevention of scars and/or keloids. The packaging, manipulation elements, applicator and/or tensioning device maybe used to apply and/or maintain a strain in an elastic dressing..
03/27/14
20140088004
Hepatocyte growth factor mimics as therapeutic agents
Small molecule, peptidic hepatocyte growth factors mimics, which act as both mimetics and antagonists, have been generated. These molecules have been shown or predicted to have therapeutic potential for numerous pathologies including dementia, neurodegenerative disease, diabetes and metabolic syndrome, cancer, and defective wound healing..
03/27/14
20140086963
Methods of wound care and treatment
Particular embodiments disclosed herein relate to gas-enriched fluids, methods of making the same, systems for making the same and/or methods of treatment utilizing the gas-enriched fluids for wound care related conditions and/or diseases. In certain embodiments, the gas-enriched fluid is oxygen-enriched water.
03/27/14
20140086886
Stem cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction
Methods for the treatment of acute renal failure, multi-organ failure, early dysfunction of kidney transplant, chronic renal failure, organ dysfunction, and wound healing are provided. The methods include delivering a therapeutic amount of hematopoietic stem cells, non-hematopoietic, mesenchymal stem cells, hemangioblasts, and pre-differentiated cells to a patient in need thereof..
03/20/14
20140081192
Primary dressing for moist wound healing, and method for producing said primary dressing
The invention relates to a primary dressing for moist wound healing with a reduced risk of inflammation. The elastic primary dressing according to the invention for moist wound healing is in the form of a lattice or a netting made of elongated elastic bodies, said lattice or netting containing non-resorbable elongated bodies that consist of silicone and optionally at least one additive selected from active pharmacological ingredients, collagens, hydrocolloids, and/or dyes.
03/20/14
20140080902
B- and y -diketones and y -hydroxyketones as wnt/ b -catenin signaling pathway activators
The present invention discloses β-diketones, γ-diketones or γ-hydroxyketones or analogs thereof, that activate wnt/β-catenin signaling and thus treat or prevent diseases related to signal transduction, such as osteoporosis and osteoarthropathy; osteogenesis imperfecta, bone defects, bone fractures, periodontal disease, otosclerosis, wound healing, craniofacial defects, oncolytic bone disease, traumatic brain injuries related to the differentiation and development of the central nervous system, comprising parkinson's disease, strokes, ischemic cerebral disease, epilepsy, alzheimer's disease, depression, bipolar disorder, schizophrenia; eye diseases such as age related macular degeneration, diabetic macular edema or retinitis pigmentosa and diseases related to differentiation and growth of stem cell, comprising hair loss, hematopoiesis related diseases and tissue regeneration related diseases.. .
03/20/14
20140080759
Compositions comprising multivalent synthetic ligands of surface nucleolin and glycosaminoglycans
The present invention relates to a composition comprising a nucant multivalent synthetic compound and a glycosaminoglycan, the admixture of both compounds forming microspheres comprising both compounds, as well as their use for the treatment or prevention of diseases associated with deregulation of proliferation and/or angiogenesis, such as cancer, inflammatory disease, or for promoting wound healing.. .
03/20/14
20140079737
Use of immunomodulatory protein in promotion of wound healing or treatment of tissue injury
The invention provides a method for promoting wound healing or tissue injury treatment in a subject in need thereof, the method comprising administering to the subject an effective amount of one or more fungal immunomodulatory protein (preferably, ganoderma immunomodulatory protein).. .
03/06/14
20140067058
Reinforced placental tissue grafts and methods of making and using the same
Described herein are tissue grafts derived from the placental tissue that are reinforced with at least one biocompatible mesh. The tissue grafts possess good adhesion to biological tissues and are useful in wound healing applications.
03/06/14
20140066786
Method and apparatus for improved wound healing and enhancement of rehabilitation
Methods and a device for improving wound healing and for improving the effects of rehabilitative therapies in patients with cognitive and motor deficits are provided. Repeated regimens of remote ischemic conditioning are performed.
03/06/14
20140065121
Blood plasma based hydrogels for tissue regeneration and wound healing applications
The present disclosure generally relates to tissue engineering and wound healing. More particularly, the present disclosure relates to the modification of plasma with a stability conferring agent to create a hydrogel for use in regenerative medicine and other tissue engineering applications..
03/06/14
20140065109
Use of substance p for mobilization of mesenchymal stem cells or proliferation of mesenchymal stem cells and for wound healing or facilitating wound healing
The present invention relates to a use of substance-p for the manufacture of a medicament for mobilization or proliferation of mesenchymal stem cells (mscs) from the bone marrow, or facilitating said mobilization or proliferation, and use of substance-p for the manufacture of a medicament for wound-healing or facilitating wound-healing.. .
03/06/14
20140065106
Blood plasma based hydrogels for tissue regeneration and wound healing applications
The present disclosure generally relates to tissue engineering and wound healing. More particularly, the present disclosure relates to the modification of plasma with a stability conferring agent to create a hydrogel for use in regenerative medicine and other tissue engineering applications..


Popular terms: [SEARCH]

Wound Healing topics: Wound Healing, Amino Acid, Amino Acid Sequence, Proliferation, Theophylline, Inflammation, Antimicrobial, Epithelial, Amino Acids, Skin Graft, Bone Healing, Vascular Disease, Skin Ulcer, Bacterial Infection, Dysfunction

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Wound Healing for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Wound Healing with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.4483

3476

0 - 1 - 71